drugset / Trial / NCT01073319
Rivastigmine as a Treatment for Methamphetamine Dependence
Phase 1
Completed
17 enrolled
Baylor College of Medicine
National Institute on Drug Abuse (NIDA) · collab
RandomizedCrossoverQuadruple-blind
Summary
To study the effects of treatment with rivastigmine on craving produced by experimental administration of methamphetamine.
Timeline
- Start
- 2009-07
- Primary completion
- 2010-07
- Completion
- 2010-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Rivastigmine | Small molecule | 1.5 mg | — |
| Comparator | Rivastigmine | Small molecule | 3 mg | — |